ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,379Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 917

$749K Total Retail Price of All Prescriptions

Rank: 35 out of 917

443 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 443 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,918 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 483 413 1 1
LEVOTHYROXINE SODIUM 414 309 2 3
ATORVASTATIN CALCIUM 407 318 3 14
METFORMIN HCL 361 294 4 8
HYDROCODONE-ACETAMINOPHEN 360 262 S3 5 6
AMLODIPINE BESYLATE 351 296 6 5
SIMVASTATIN 331 278 7 2
LOSARTAN POTASSIUM 305 253 8 13
OMEPRAZOLE 294 215 9 4
CRESTOR 227 169 10 30
FUROSEMIDE 206 175 11 7
ZOLPIDEM TARTRATE 202 154 12 21
METOPROLOL TARTRATE 173 143 13 11
CYMBALTA 169 57 14 56
RANITIDINE HCL 163 141 15 29
SERTRALINE HCL 158 140 16 24
POTASSIUM CHLORIDE 148 144 17 16
ATENOLOL 147 107 18 12
NAMENDA 142 142 19 43
PRAVASTATIN SODIUM 139 119 20 20
METOPROLOL SUCCINATE 132 129 21 18
HYDROCHLOROTHIAZIDE 127 95 22 9
CITALOPRAM HBR 126 101 23 15
LANTUS SOLOSTAR 119 81 24 63
DONEPEZIL HCL 119 107 24 32
WARFARIN SODIUM 115 107 26 10
GABAPENTIN 103 77 27 17
LIPITOR 102 79 28 89
NEXIUM 97 59 29 60
CLOPIDOGREL 93 83 30 50
LOVASTATIN 93 68 30 19
SYNTHROID 92 82 32 68
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 76 33 42
ALENDRONATE SODIUM 78 70 34 23
PLAVIX 74 70 35 84
MORPHINE SULFATE ER 73 35 S2 36 48
PREDNISONE 71 70 37 34
FLUTICASONE PROPIONATE 67 43 38 26
OXYCODONE-ACETAMINOPHEN 66 47 S2 39 46
GEMFIBROZIL 65 32 40 140
TRAZODONE HCL 62 48 41 22
CYCLOBENZAPRINE HCL 62 40 R 41 65
TAMSULOSIN HCL 60 40 43 25
CARVEDILOL 58 37 44 33
QUETIAPINE FUMARATE 57 57 45 52
PAROXETINE HCL 57 49 45 57
LEVOXYL 57 54 45 142
ESCITALOPRAM OXALATE 57 57 45 114
LANTUS 56 44 49 37
DIGOXIN 55 51 50 41
PEN NEEDLE 54 52 51 99
ALLOPURINOL 54 39 51 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.